Marico has officially completed the acquisition of a 75% stake in SkinEtiq Joint Stock Company, a Vietnamese digital skincare brand, through its wholly owned subsidiary MSEA (Marico South East Asia Corporation) on April 2, 2026. The transaction was formally announced to stock exchanges under Regulation 30 of SEBI listing requirements, making SkinEtiq a subsidiary of MSEA and consequently a subsidiary of Marico Limited.

Transaction Completion and Regulatory Filing

The acquisition was completed on April 2, 2026, following the initial proposal announced on February 9, 2026. Marico informed both BSE and NSE about the successful completion of this strategic transaction, which transforms SkinEtiq into a subsidiary within the company's organizational structure.

SkinEtiq's Digital Skincare Portfolio

SkinEtiq operates as a digital-first skincare company in Vietnam, owning the 'Candid' brand and holding exclusive distribution rights for the 'Murad' brand in the Vietnamese market. This acquisition provides Marico with access to established digital skincare brands and distribution networks in the growing Vietnamese beauty market.

Strategic Expansion in Southeast Asia

The completed acquisition represents Marico's continued commitment to expanding its presence in Southeast Asian markets through strategic investments. By securing a controlling stake in SkinEtiq, the company gains access to local market expertise, established consumer base, and digital-first capabilities in the Vietnamese skincare segment.

Corporate Structure Enhancement

With the transaction's completion, SkinEtiq becomes a subsidiary of MSEA, which is itself a wholly owned subsidiary of Marico Limited. This structured approach allows Marico to leverage its international subsidiary framework for effective management and integration of the Vietnamese operations while maintaining strategic control over the digital skincare expansion.

The acquisition strengthens Marico's digital capabilities in the personal care segment and provides a platform for further growth in the Vietnamese and broader Southeast Asian markets.

Source: Company/INE196A01026/0661d7aa-6881-4c2a-85ff-199dcaf7f261.pdf

Marico has delivered robust performance in Q4 FY26, with consolidated revenue growing in the low twenties year-on-year during the quarter. The consumer goods company expects double-digit operating profit growth with sequential improvement, driven by strong operational performance across business segments.

Financial Performance Overview

The company's Q4 FY26 performance demonstrates strong momentum across key metrics:

India Business Segment Performance

The India business sustained high single-digit underlying volume growth with slight sequential improvement. Parachute continued showcasing resilience, taking selective pricing actions amid easing copra prices and recording low single-digit volume growth after normalizing for ml-age reductions. Saffola Oils recorded high single-digit revenue growth driven by improving volume traction.

Value Added Hair Oils registered another robust quarter with growth in the twenties, reinforcing sustained franchise traction. Foods delivered high teens value growth, marking progressive movement towards accelerated growth trajectory. Premium Personal Care including digital-first brands continued scaling ahead of aspirations, sustaining diversification pace.

International Business Momentum

The International business maintained stellar momentum with constant currency growth in high teens. Each market contributed positively except the Gulf region, which was impacted by ongoing geopolitical headwinds in March.

Market Outlook and Input Costs

Copra prices corrected approximately 35% from peak levels and are expected to remain rangebound. While vegetable oils and crude-sensitive materials exhibit upward bias, the company will judiciously exercise pricing power to alleviate impact while maintaining assured availability. Sequential gross margin improvement is expected driven by easing copra prices.

Growth Strategy and Future Aspirations

Marico remains confident of delivering healthy volume-led revenue growth in FY27, supported by strategic focus on mid and premium segments, enhanced direct reach through Project SETU, differentiated innovation pipeline, and improved affordability due to GST rate rationalization. The company maintains its aspiration of delivering sustainable and profitable volume-led growth over the medium term.